Please login to the form below
Pharma Mar
This page shows the latest Pharma Mar news and features for those working in and with pharma, biotech and healthcare.
ViiV’s two-drug HIV combo backed by CHMP
abaloparatide) and confirming its earlier rejection of Pharma Mar’s Aplidin (plitidepsin) as a treatment for multiple myeloma.
Latest news
-
Novartis curates interactive history of medicine exhibition
Another firm active in this space is Pharma Mar, whose marine-derived antitumoral agent Yondelis (trabectedin) received US approval last month to treat unresectable or metastic liposarcoma or leiomyosarcoma. . ... Digital inspiration for pharma on mobile
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Associate Medical Director
-
Highly Competitive
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Director Healthcare PR Communications
-
Salary TBC
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
-
Account Director - Digital
-
Great salary and benefits
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Experienced Editor, London, Medical Communications
-
Competitive package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Account Director
-
Negotiable
- Account Manager, Healthcare Advertising
-
Salary TBC
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Associate Medical Director
-
Salary TBC
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
Subscribe to our email news alerts
- Retaining reader value in plain language summaries of clinical studies
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- 90TEN wins big at PRWeek Awards taking home six accolades including Mid-Sized and Specialist Consultancy of the Year
- The NHS in 2022: how pharma can contribute to new models of care
- Genomics England chooses Congenica for diagnostic decision support
- Ocrevus surge keeps Roche smiling in Q3
PMHub
GCI Health
GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
Quick links
Infographics
